Stopping statins after stroke raises risk of death, dependency

Aug 27, 2007

People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the August 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

The study found that people who stopped taking their cholesterol-lowering drugs, also called statins, while hospitalized after a stroke were 4.7 times more likely to have died or be dependent on others for their care three months after the stroke than people who kept taking the drugs.

“These results strongly support the recommendation to physicians to continue statin drugs during the acute phase of an ischemic stroke,” said study author José Castillo, MD, PhD, of the University of Santiago de Compostela in Santiago de Compostela, Spain.

Castillo said that while no protocols suggest that patients should not receive statins after a stroke, in many cases the drugs are discontinued to avoid problems that can occur when stomach content is regurgitated into the lungs. “This study clearly shows the benefits of continuing statin use,” he said.

The study involved 89 people who were already taking the cholesterol-lowering drugs at the time when they had a stroke. For the first three days after being admitted to the hospital, 46 of the people received no statin drugs and 43 received the drugs.

After three months, 27 people, or 60 percent, of the group that received no statins had either died or were disabled to the point that they could not complete their daily activities independently, compared to 16 people, or 39 percent, of the group that kept taking statins.

Previous studies have shown that people who are taking statins at the time of a stroke have less severe strokes than those who aren’t taking statins.

Statins appear to do more than reduce cholesterol. They also reduce inflammation and help keep the blood from clotting, which can cause stroke. Statins also increase the release of nitric oxide, which is protective, from the cells lining artery walls.

Source: American Academy of Neurology

Explore further: Hearing quality restored with bionic ear technology used for gene therapy

add to favorites email to friend print save as pdf

Related Stories

Cholesterol: The good, the bad, the unknown

Feb 21, 2011

Two people are diagnosed with high cholesterol, one of the leading risk factors for heart disease, and follow similar therapies. One ends up with improved cholesterol levels, but the other doesn't.

Statin benefit 'not affected' by low inflammation

Jan 28, 2011

(PhysOrg.com) -- A new Oxford-led study shows that statins are at least as effective in reducing the risk of heart attack or stroke in patients with low levels of inflammation as they are in other patients.

Statins less dangerous than thought for liver patients

Nov 24, 2010

Long-term use of statins, a drug widely prescribed to prevent artery-blocking cholesterol, is less risky than thought for patients with a common form of liver disease, according to a study published on Wednesday by The La ...

Major international study to test new heart disease drug

Nov 18, 2010

(PhysOrg.com) -- A major international study to test whether a new type of cholesterol treatment can prevent coronary deaths and heart attacks will start in early 2011. The study will be coordinated by the ...

Recommended for you

LED exposure is not harmful to human dermal fibroblasts

Apr 23, 2014

There was a time when no one thought about light bulbs—one blew, you screwed another one in. Nowadays, it's more complicated, as energy efficiency concerns have given rise to a slew of options, including ...

User comments : 0

More news stories

New breast cancer imaging method promising

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Breast cancer replicates brain development process

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

Research proves nanobubbles are superstable

The intense research interest in surface nanobubbles arises from their potential applications in microfluidics and the scientific challenge for controlling their fundamental physical properties. One of the ...

Using antineutrinos to monitor nuclear reactors

When monitoring nuclear reactors, the International Atomic Energy Agency has to rely on input given by the operators. In the future, antineutrino detectors may provide an additional option for monitoring. ...